Galt Associates   
July 15, 2006
Acquired by the Cerner Corporation (NASDAQ: CERN) in July, 2006, Galt Associates is an example of Boston Millennia Partners’ expertise in the healthcare information technology sector and their commitment to help dedicated management teams grow their companies over the long run. Founded in 1994, Galt Associates is recognized as an international leader in the drug safety and risk management solutions industries. Boston Millennia Partners began its relationship with Galt in 2001 as the lead investor in its original Series A financing. Represented at the board level by Partner Robert Jevon, Millennia worked with Galt’s founders to grow the business from a niche software company in the drug safety market to a complete pharmacovigilence solutions provider. During Millennia’s tenure as investors in Galt, the company developed new products to complement its initial offering and in doing so created a comprehensive solutions suite to fit the needs of life science companies of all sizes. In their five years working with the company, Millennia also helped Galt extensively expand its consulting services to complement its software solutions. At the time of sale, Galt counted 16 of the world’s 20 largest life science companies as customers and had tripled its sales since Millennia made its initial investment. Having the prescience to invest in the pharmacovigilence space ahead of the FDA’s increasing of post-clinical regulatory requirements, Cerner’s all cash acquisition of the company provided Millennia with a strong return for the firm’s Limited Partners.